The pro-inflammatory cytokine tumor necrosis factor (TNF)-α plays a key role in RA pathogenesis, and TNF-α inhibition has demonstrated positive clinical outcomes [1, 2]. This evidence concerns the gene TNF and rheumatoid arthritis.